• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
Back

Corporate News

Senores Pharmaceuticals confirms proper use of Rs 500 crore IPO proceeds, CARE Ratings monitors
29-Oct-2026, 05:51

Senores Pharmaceuticals Limited reported no deviation or variation in the utilization of proceeds from its initial public offering during the quarter ended September 30, 2026, according to a filing with the Bombay Stock Exchange and National Stock Exchange. The company had raised Rs 500 crore through the IPO on December 26, 2024, and CARE Ratings Limited is the monitoring agency for the funds.